These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34971362)

  • 1. Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
    Chow EPF; Fairley CK; Zou H; Wigan R; Garland SM; Cornall AM; Atchison S; Tabrizi SN; Chen MY
    Clin Infect Dis; 2022 Aug; 75(2):323-329. PubMed ID: 34971362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
    Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY
    Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women.
    Winer RL; Lin J; Querec TD; Unger ER; Stern JE; Rudd JM; Golden MR; Swanson F; Markowitz LE; Meites E
    J Infect Dis; 2022 Feb; 225(3):422-430. PubMed ID: 34320185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
    Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
    Woestenberg PJ; van Benthem BHB; Bogaards JA; King AJ; van der Klis FRM; Pasmans H; Leussink S; van der Sande MAB; Hoebe CJPA;
    Vaccine; 2020 Apr; 38(17):3321-3329. PubMed ID: 32201140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London.
    King EM; Mesher D; Sonnenberg P; Linley E; Panwar K; Beddows S; Soldan K; Borrow R; Jit M; Gilson R
    Sex Transm Infect; 2021 Aug; 97(5):382-386. PubMed ID: 33361466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study.
    Loenenbach A; Schönfeld V; Takla A; Wiese-Posselt M; Marquis A; Thies S; Sand M; Kaufmann AM; Wichmann O; Harder T
    Front Public Health; 2023; 11():1204101. PubMed ID: 37719724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anal Human Papillomavirus Prevalence Among Vaccinated and Unvaccinated Gay, Bisexual, and Other Men Who Have Sex With Men in Canada.
    Chambers C; Deeks SL; Sutradhar R; Cox J; de Pokomandy A; Grennan T; Hart TA; Lambert G; Moore DM; Coutlée F; Burchell AN;
    Sex Transm Dis; 2022 Feb; 49(2):123-132. PubMed ID: 34561370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
    Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
    J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.
    Van Keer S; Willhauck-Fleckenstein M; Pattyn J; Butt J; Tjalma WAA; Van Ostade X; Hens N; Van Damme P; Waterboer T; Vorsters A
    J Clin Virol; 2019 Aug; 117():11-18. PubMed ID: 31129514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccine.
    Rowhani-Rahbar A; Alvarez FB; Bryan JT; Hughes JP; Hawes SE; Weiss NS; Koutsky LA
    J Clin Virol; 2012 Mar; 53(3):239-43. PubMed ID: 22209292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings.
    Donkoh ET; Dassah ET; Owusu-Dabo E
    BMC Womens Health; 2022 Jun; 22(1):234. PubMed ID: 35710373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Mehta PA; Sauter S; Zhang X; Davies SM; Wells SI; Myers KC; Panicker G; Unger ER; Butsch Kovacic M
    Vaccine; 2017 Dec; 35(48 Pt B):6712-6719. PubMed ID: 29042204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.
    Hernández-Ávila M; Torres-Ibarra L; Stanley M; Salmerón J; Cruz-Valdez A; Muñoz N; Herrero R; Villaseñor-Ruíz IF; Lazcano-Ponce E
    Hum Vaccin Immunother; 2016; 12(1):30-8. PubMed ID: 26211489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing knowledge of human papillomavirus among men who have sex with men (MSM) using targeted dating applications.
    Pham D; Shukla A; Welch K; Villa A
    Vaccine; 2022 Aug; 40(36):5376-5383. PubMed ID: 35945045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18.
    Trevisan A; Wissing MD; Dagenais C; Forest P; Ramanakumar AV; Burchell AN; Franco EL; Coutlée F; Couillard M
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 34043499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys.
    Middeldorp M; Duijster JW; van de Kassteele J; van der Klis FRM; de Melker HE
    Front Immunol; 2024; 15():1327770. PubMed ID: 38343547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
    Mariz FC; Gray P; Bender N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel HM; Waterboer T; Müller M; Pawlita M; Lehtinen M
    Lancet Infect Dis; 2021 Oct; 21(10):1458-1468. PubMed ID: 34081923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccination coverage among men who have sex with men-National HIV Behavioral Surveillance, United States, 2017.
    McClung N; Burnett J; Wejnert C; Markowitz LE; Meites E;
    Vaccine; 2020 Nov; 38(47):7417-7421. PubMed ID: 33046266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.